Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ERA 25: Switching from sMRAs to Finerenone
Author(s): Beatriz Fernandez Fernandez Added: 8 months ago
ERA 2025 - Real-world outcomes show switching from treatment with steroidal mineralocorticoid receptor antagonists (sMRAs) to finerenone is a safe option in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D).Dr Beatriz Fernandez Fernandez (Hospital Universitario Fundación Jiménez Dïaz, Madrid, ES) joins us to discuss real-world outcomes from a study investigating the effect of… View more

Cardiovascular Renal Metabolic
ERA Congress 2025 Late-Breaking Collection
Author(s): William Herrington Added: 9 months ago
Keep up-to-date with the late-breaking presentations from the European Renal Association's 62nd congress, taking place from 4th to 7th June 2025 in Vienna. With Expert Interviews focusing on the applicability of the latest data and Highlights summarising the key take-aways, our video collection has you covered. View more

Cardiovascular Renal Metabolic
ERA 25: Treating Obesity in 2025 and Beyond
Author(s): Ruben Nogueiras Added: 8 months ago
ERA 2025 - Dr Ruben Nogueiras (University of Santiago de Compostela, Santiago, ES) joins us to discuss upcoming treatments that will soon be approved for the treatment of obesity, including dual agonists that will also target type two diabetes. As well as exploring the evolution of our understanding and classification of obesity, Dr Nogueiras shares his view of obesity a multifactorial disease… View more

Cardiovascular Renal Metabolic
Real-World Data for CV and Renal Outcomes in DKD
Author(s): David Wheeler Added: 9 months ago
ERA 2025 - Prof David Wheeler (University College London, London, UK) joins us to discuss outcomes from real-world data investigating cardiovascular and renal outcomes in patients with DKD.Interview Questions:1. How do real-world cardiovascular and renal outcomes compare to clinical trial results, and which data sources are giving us the best insights into DKD outcomes?2. What's the biggest gap… View more

Cardiovascular Renal Metabolic
ERA 25: Albuminuria, eGFR Dip and Disease Severity & Empagliflozin
Author(s): William Herrington Added: 8 months ago
ERA 2025 - Findings from a meta-analysis of chronic kidney disease outcomes in patients treated with empagliflozin suggest that people with CKD benefit from the drug irrespective of diabetes of albuminuria status.ProfWilliam Herrington (University of Oxford, Oxford, UK) joins us to discuss outcomes from an individual patient-level data meta-analysis, investigating the impact of diabetes,… View more

Cardiovascular Renal Metabolic
ERA 25: eGFR Dips and Disease Severity on Empagliflozin
Author(s): Added: 9 months ago
ERA 2025 - Results from a meta-analysis of trials including EMPA-KIDNEY show the treatment effect of empagliflozin is not modified by level of predicted acute eGFR dip.Dr Natalie Staplin (University of Oxford, Oxford, UK) joins us to discuss findings from a meta-analysis of four trials, including the EMPA-KIDNEY trial (NCT03594110), investigating the impact of acute eGFR dips and markers of… View more

Cardiovascular Renal Metabolic
Bridging the Gap in Cardio-Renal Care
Author(s): Paola Fioretto , Rajiv Agarwal Added: 9 months ago
Filmed on location at ERA 2025 in Vienna, Austria, this three-part video series brings together internationally recognised experts Prof Rajiv Agarwal (Indiana University School of Medicine, Indianapolis, US) and Prof Paola Fioretto (University of Padova, Padova, IT) for an insightful peer-to-peer discussion on the latest advances in chronic kidney disease (CKD) and cardio-renal management… View more

Cardiovascular Renal Metabolic

Guidelines & Statements
TTE and TEE in the New TAVR Era with Dr Victoria Delgado
Author(s): Victoria Delgado Added: 7 months ago
Navigate the evolving landscape of TAVI beyond conventional applications with Dr Victoria Delgado.This presentation, part of the Structural Interventions track, explores specialized applications including TAVI in small aortic annulus, examining insights from the SMART and RHEIA trials that demonstrate superior hemodynamics of transcatheter approaches, particularly in women who present with… View more

Demographic

Intervention
Medical Publishing in an Era of Disinformation with Dr Joseph Hill
Author(s): Joseph A Hill , Harriette Van Spall Added: 11 months ago
In this engaging episode of Masterclass filmed at the ACC, host Dr Harriette Van Spall (McMaster University, Hamilton, CA) sits down with Dr Joseph Hill (UT Southwestern Medical Center, Dallas, TX, US) for a thought-provoking conversation about his career journey, the challenges of medical misinformation, and the critical importance of effective scientific communication.Together, they explore the… View more

Guidelines & Statements
Navigating Digital Medical Education
Author(s): Gurleen Kaur , Saman Nematollahi , Thomas Das , et al Added: 1 year ago

Guidelines & Statements